COVID-19 - International Pharmaceutical Industry

News

AstraZeneca’s long-acting antibody combination treats and prevents COVID-19

Positive high-level results from the TACKLE Phase III COVID-19 treatment trial have shown that AstraZeneca’s AZD7442, a long-acting antibody (LAAB) combination, achi...

13 October 2021 News antibody | AstraZeneca

Continue Reading →

News

AiPharma forms alliance with Appili Therapeutics

Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Th...

6 October 2021 News AiPharma | Appili Therapeutics

Continue Reading →

News

CHMP positive option for Pfizer-BioNTech COVID-19 vaccine in the EU

Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the administration of the Pfizer-...

6 October 2021 News BioNTech | booster shot

Continue Reading →

News

Largest COVID-19 PCR provider announces expansion of ‘cube’ labs

The UK’s largest laboratory diagnostics company, Randox, has announced a nationwide expansion of ten new adaptive ‘cube’ laboratories across Great Britain, with faci...

6 October 2021 News ‘cube’ laboratories | COVID testing

Continue Reading →

News

Merck announces its antiviral COVID-19 pill halves hospitalisations and deaths

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that molnupiravir (MK-4482, EIDD-2801), an investigational ora...

6 October 2021 News COVID-19 | COVID-19 pill

Continue Reading →

News

Positive topline results for Pfizer/BioNTech jab in five to 11-year-olds

Pfizer and BioNTech have announced that their COVID-19 vaccine is safe for use in children aged five to 11 years old. Results from a Phase II/III trial showed a f...

22 September 2021 News BioNTech | children aged five to 11

Continue Reading →

News

AdaCore’s QGen automated code generator helps develop new artificial lung equipment to treat Covid patients in only six months

Leading provider of software development and verification tools, AdaCore, has joined forces with the Eldorado Institute in Brazil and medical device manufacturer Bra...

15 September 2021 News AdaCore | artificial lung equipment

Continue Reading →

News

UK Government terminates COVID-19 vaccine agreement with Valneva

The French speciality vaccine company, Valneva, has announced that it has received a termination notice from the UK Government in relation to the Supply Agreement fo...

15 September 2021 News COVID-19 | manufacturing

Continue Reading →

Volume 13 Issue 3

Changing the Face of Infection Prevention

As we approach the 18-month mark since the onset of COVID-19, the greatest global pandemic of our times, many are turning their attention to what seems to be the nex...

13 September 2021 Volume 13 Issue 3 AMR | antimicrobial resistance

Continue Reading →

News

Gov’t injects £5.4bn to support NHS England’s COVID-19 response

The government has announced an extra £5.4bn funding injection into the NHS in England in a bid to tackle backlogs caused by the COVID-19 pandemic. The funding wi...

8 September 2021 News COVID-19 | Department of Health and Social Care

Continue Reading →